Australian Journal of Primary Health,
Год журнала:
2019,
Номер
26(1), С. 24 - 24
Опубликована: Ноя. 17, 2019
This
qualitative
study
explored
GPs'
experiences
with
pharmacist-led
home
medicines
reviews
(HMRs)
and
the
barriers
facilitators
to
GPs
using
HMRs
optimise
for
older
people.
Semi-structured
interviews
were
conducted
32
Australia-wide.
Purposeful
sampling
was
undertaken
obtain
a
representative
group
in
terms
of
age,
gender
location.
Data
analysed
framework
analysis.
Overall,
found
useful
educating
patients
about
their
medicines,
improving
adherence
understanding
patient's
environment.
Barriers
effective
use
included
patient
resistance
having
reviewed
limited
access
regional
or
rural
areas.
differed
extent
way
they
HMRs.
One
very
useful,
wanted
more
reported
frequent
interactions
pharmacists.
A
second
ambivalent,
perceived
could
be
but
had
limitations
what
can
achieve.
third
sceptical,
rarely
provide
new
insights,
recommendations
not
clinically
relevant
patients.
Understanding
expectations
preferences
through
interprofessional
communication
partnerships
are
ways
address
these
barriers.
Future
improvements
HMR
program
may
include
incentives
resources
that
promote
collaboration
between
British Journal of Clinical Pharmacology,
Год журнала:
2014,
Номер
78(4), С. 738 - 747
Опубликована: Март 25, 2014
Inappropriate
use
of
medication
is
widespread,
especially
in
older
people,
and
associated
with
risks,
including
adverse
drug
reactions,
hospitalization
increased
mortality.
Optimization
appropriate
to
minimize
these
harms
an
ongoing
challenge
healthcare.
The
term
‘deprescribing’
has
been
used
describe
the
complex
process
that
required
for
safe
effective
cessation
medication.
Patients
play
important
role
their
own
health
and,
while
they
may
complain
about
number
medications
have
take,
also
be
reluctant
cease
a
when
given
opportunity
do
so.
A
review
previously
proposed
deprescribing
processes
relevant
literature
was
develop
patient‐centred
process,
which
five‐step
cycle
encompasses
gaining
comprehensive
history,
identifying
potentially
inappropriate
medications,
determining
whether
can
ceased,
planning
withdrawal
regimen
(e.g.
tapering
where
necessary)
provision
monitoring,
support
documentation.
This
first
developed
using
knowledge
patients'
views
cessation;
it
focuses
on
engaging
patients
throughout
aim
improving
long‐term
outcomes.
Despite
literature,
there
still
lack
evidence
base
conduct
deprescribing.
next
step
broadening
will
test
determine
feasibility
clinical
setting.
Health and Quality of Life Outcomes,
Год журнала:
2011,
Номер
9(1), С. 95 - 95
Опубликована: Янв. 1, 2011
Modern
drugs
have
made
large
contributions
to
better
health
and
quality
of
life.
Increasing
proportions
negative
side
effects
due
extensive
pharmacological
treatment
are
however
observed
especially
among
elderly
patients
who
multiple
problems.
The
aim
our
study
was
see
if
there
is
an
association
between
medication
150
discharged
from
hospital.
Inclusion
criteria
were:
living
in
ordinary
homes,
≥
75
years
5
drugs.
Home
visits
were
performed
all,
including
prescription
reviews
calculation
appropriateness
index.
divided
into
three
groups
depending
on
index
score
followed
for
12
months.
validated
recognized
EQ-5D
EQ
VAS
instruments
used
assess
A
lower
associated
with
a
statistically
significantly
different
(declining
each
group)
the
(p
=
0.001
at
start,
p
6
months
0.013
months)
as
0.026
0.003
0.007
months).
This
has
shown
validity
basic
principle
prescribing:
more
appropriate
Since
drug
related
patients'
life,
immense
reason
continuously
evaluate
every
treatment.
evaluation
possible
deprescribing
should
be
done
process
where
both
patient
physician
involved.
Clinical Interventions in Aging,
Год журнала:
2006,
Номер
1(1), С. 11 - 31
Опубликована: Янв. 1, 2006
Reducing
food
intake
in
lower
animals
such
as
the
rat
decreases
body
weight,
retards
many
aging
processes,
delays
onset
of
most
diseases
old
age,
and
prolongs
life.A
number
clinical
trials
restriction
healthy
adult
human
subjects
running
over
2-15
years
show
significant
reductions
blood
cholesterol,
glucose,
pressure,
which
are
risk
factors
for
development
cardiovascular
disease
diabetes.Lifestyle
interventions
that
energy
balance
by
reducing
weight
physical
exercise
can
also
delay
diabetes
disease.In
general,
suggesting
diets
high
calories
or
fat
along
with
overweight
associated
increased
disease,
type
2
diabetes,
some
cancers,
dementia.There
is
a
growing
literature
indicating
specific
dietary
constituents
able
to
influence
age-related
diseases,
including
certain
fats
(trans
fatty
acids,
saturated,
polyunsaturated
fats)
cholesterol
glycemic
index
fiber
fruits
vegetables
calcium
vitamin
D
osteoporosis
bone
fracture.In
addition,
there
compounds
from
different
functional
foods,
herbs,
neutraceuticals
ginseng,
nuts,
grains,
polyphenols
may
affect
diseases.Long-term
prospective
will
be
needed
confirm
these
diet-disease
relationships.On
basis
current
research,
best
diet
one
low
saturated
wholegrain
cereals,
legumes,
vegetables,
maintains
lean
weight.Such
should
become
key
component
aging,
delaying
agerelated
perhaps
intervening
process
itself.Furthermore,
studies
nutrition
childhood
even
fetus
later
lifespan.
Expert Opinion on Drug Delivery,
Год журнала:
2014,
Номер
11(7), С. 1103 - 1111
Опубликована: Июнь 4, 2014
Introduction:
Levothyroxine
(l-T4)
is
the
mainstay
of
treating
hypothyroidism.
The
tablet
traditional
formulation
l-T4.
Tablet
l-T4
malabsorption
results
from
either
hindered
gastric
dissolution
or
binding
by
sequestrants
in
intestinal
lumen.Areas
covered:
This
review
provides
an
overview
pharmacokinetics
formulations
available
market:
tablet,
soft
gel
capsule
and
oral
solution.
We
literature
on
new
anticipate
areas
future
research.Expert
opinion:
Failure
treatment
to
reach
target
serum
thyroid-stimulating
hormone
levels
generally
prompts
physicians
increase
daily
dose.
In
vitro
studies
have
shown
that
releases
active
ingredient
more
consistently
at
varying
pH
than
tablet.
addition,
vivo
confirmed
data
demonstrated
both
liquid
are
capable
solve
caused
certain
drugs,
bariatric
surgery
coffee.
These
may
be
attractive
also
for
patients
who
cannot/do
not
want
change
their
(improper)
habits
ingestion.
Finally,
solution
could
suitable
cannot
swallow
solid
formulations.
Therapeutic Advances in Drug Safety,
Год журнала:
2011,
Номер
2(2), С. 37 - 43
Опубликована: Фев. 28, 2011
Objective:
Polypharmacy
and
adverse
drug
reactions
are
frequent
important
among
older
people.
Few
clinical
trials
have
evaluated
systematic
withdrawal
of
medications
This
small,
open,
study
was
conducted
to
determine
the
feasibility
a
randomized
controlled
deprescribing
trial.
Methods:
Ten
volunteers
living
in
community
(recruited
by
media
advertising)
25
residential
aged-care
facilities
(RCFs)
were
intervention
or
control
groups.
The
gradual
one
target
medication.
primary
outcome
number
participants
whom
medication
could
be
achieved.
Other
outcomes
measures
quality
life,
adherence,
sleep
quality,
cognitive
impairment.
Results:
Participants
aged
80
±
11
years
taking
9
2
medications.
Fifteen
commenced
all
ceased
reduced
dose
their
Two
subjects
withdrew;
referred
for
review,
participant
declined
further
reductions.
Conclusions:
A
trial
acceptable
participants.
Recruitment
RCFs
is
feasible.
Definitive
required.
Current Opinion in Endocrinology Diabetes and Obesity,
Год журнала:
2013,
Номер
20(5), С. 467 - 477
Опубликована: Авг. 23, 2013
Purpose
of
review
In
this
article,
we
will
consider
the
failure
thyroid
hormone
replacement
therapy
to
normalize
serum
stimulating
concentrations.
We
circumstances
and
causes
for
failures,
discuss
pertinent
unpublished
personal
cases
didactical
value,
provide
practical
suggestions
providers
encountering
patients
with
similar
presentations.
Recent
findings
data
are
available
on
benefit
novel
formulations
levothyroxine
malabsorption.
Summary
Most
frequently,
reasons
ineffectiveness
noncompliance,
inappropriate
administration
levothyroxine,
gastrointestinal
disorders,
drug
interactions.
The
diagnostic
work-up
should
include
careful
history
elucidate
potential
ineffective
therapy.
Dementia and Geriatric Cognitive Disorders Extra,
Год журнала:
2012,
Номер
2(1), С. 361 - 371
Опубликована: Сен. 7, 2012
<b><i>Background:</i></b>
Use
of
potentially
harmful
medications
(PHMs)
is
common
in
people
with
dementia
living
Residential
Aged
Care
Facilities
(RACFs)
and
increases
the
risk
adverse
health
outcomes.
Debate
persists
as
to
how
PHM
use
its
association
quality
life
should
be
measured.
We
designed
this
study
determine
exposure
PHM,
operationalized
by
three
different
measures,
self-reported
Health-Related
Quality
Life
among
residing
RACFs.
<b><i>Methods:</i></b>
Cross-sectional
351
aged
>65
years
diagnosed
RACFs
MMSE
≤24.
The
primary
outcome
measure
was
self-rated
–
Alzheimer’s
disease
questionnaire
(QoL-AD).
collected
data
on
patients’
medications,
age,
gender,
total
score,
Neuropsychiatric
Inventory
comorbidities.
Using
regression
analyses,
we
calculated
crude
adjusted
mean
differences
between
groups
exposed
not
according
inappropriate
(PIMs;
identified
Modified
Beers
criteria),
Drug
Burden
Index
(DBI)
>0
polypharmacy
(i.e.
≥5
medications).
<b><i>Results:</i></b>
Of
226
participants
able
rate
their
QoL-AD,
56.41%
were
at
least
one
PIM,
82.05%
medication
contributing
DBI
>0,
91.74%
polypharmacy.
Exposure
PIMs
associated
QoL-AD
ratings,
while
(also
after
adjustment);
tripled
odds
lower
ratings.
<b><i>Conclusion:</i></b>
medications),
but
(Modified
inversely
health-related
for